|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1995-1-13
|
|
pubmed:abstractText |
Suramin has shown promising activity against prostate and breast cancer but is severely neurotoxic. Complex adaptive pharmacokinetics have previously been used to adjust doses. We have undertaken a pilot study to assess the feasibility of administering suramin to outpatients with advanced cancer, using simple peak and trough monitoring.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
597-600
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7993834-Adult,
pubmed-meshheading:7993834-Aged,
pubmed-meshheading:7993834-Ambulatory Care,
pubmed-meshheading:7993834-Breast Neoplasms,
pubmed-meshheading:7993834-Drug Administration Schedule,
pubmed-meshheading:7993834-Feasibility Studies,
pubmed-meshheading:7993834-Female,
pubmed-meshheading:7993834-Humans,
pubmed-meshheading:7993834-Infusions, Intravenous,
pubmed-meshheading:7993834-Male,
pubmed-meshheading:7993834-Middle Aged,
pubmed-meshheading:7993834-Pilot Projects,
pubmed-meshheading:7993834-Prostatic Neoplasms,
pubmed-meshheading:7993834-Suramin
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Suramin for breast and prostate cancer: a pilot study of intermittent short infusions without adaptive control.
|
|
pubmed:affiliation |
CRC Department of Medical Oncology, Christie Hospital, Manchester, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
